Disclaimer: This site analyses public FDA records. It is not medical advice. If you feel unwell, contact a healthcare professional immediately.
Supplement Safety Checker
Notice: Official Public Record

Black Seed Herb, Inc. FDA Warning (2017)

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on July 11, 2017

MODERATE SEVERITY New York District Office 2017
Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Black Seed Herb, Inc. on July 11, 2017 citing misbranding, cgmp violations, labeling violations. The letter was issued by New York District Office.

Misbranding CGMP Violations Labeling Violations

Detailed Analysis

False Claims and Regulatory Violations

You failed to establish and follow written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision, as required by 21 CFR 111.103 and 111.140(b)(1). Specifically, you acknowledged to our investigators that you have not established any written procedures for quality control operations. In addition, for the products that are manufactured, packaged, and labeled by your contract manufacturer (including Diabalance Herbal Blood Sugar, Black Cumin Seed Oil Softgel, and Quick Slim with pure Hoodia Gordonii) you do not perform quality control functions, such as reviewing and approving the documentation to determine whether the received product meets the specifications that you established

Potential Health Risks

Your QuickSlim with pure Hoodia Gordonii, Black seed herb brand Sweet Excitement Her Honey, Sweet Sunnah brand Bhealthy Blood Sugar Black Seed with Bitter Melon, and Sweet Sunnah brand Black Seed Honey Booster products are misbranded within the meaning of 403(s)(2)(B) of the Act [21 U.S.C. § 343 (s)(2)(B)] because the labels fail to include a statement of identity as a “dietary supplement” as required by 21 CFR 101.3(g).

Your QuickSlim with pure Hoodia Gordonii, Sweet Sunnah brand Flax Seed Oil, Sweet Sunnah brand Black Seed Oil, 8 ounces, Black Seed Oil, 32 ounces and Black Seed Oil, softgels,and Sweet Sunnah brand Bhealthy Blood Sugar Black Seed with Bitter Melon products are misbranded within the meaning of section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] in that the labels fail to declare all the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4. Specifically,Your QuickSlim with pure Hoodia Gordonii product label declares the dietary ingredient galangal, but this is not a standardized common name noted in the reference Herbs of Commerce.Your Sweet Sunnah brand Flax Seed Oil product label declares the dietary ingredient lignan (SDG), but this is not a common

Your Sweet Sunnah brand Bhealthy Blood Sugar Black Seed with Bitter Melon label fails to list the capsule ingredients.

Regulatory Context

You failed to establish product specifications for each dietary supplement that you manufacture for the identity, purity, strength, and composition of the finished batch of the dietary supplement, and for limits on those types of contamination that may adulterate, or that may lead to adulteration of, the finished batch of the dietary supplement to ensure the quality of the dietary supplement, as required by 21 CFR 111.70(e). Specifically, your firm has not established finished product specifications for any of the dietary supplement products that you manufacture and distribute. For example, our investigators observed that you had not established finished product specifications for the following products:

You failed to establish specifications to provide sufficient assurance that the product you receive from a supplier for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier) is adequately identified and is consistent with your purchase order, as required by 21 CFR 111.70(f). Specifically, your firm has not established these specifications for any of the products that you receive from a supplier for packaging or labeling as a dietary supplement. For example, our investigators observed that you had not established these specifications for the following products:

You failed to prepare and follow a written master manufacturing record (MMR) for each unique formulation of dietary supplement that you manufacture, and for each batch size, to ensure uniformity in the finished batch from batch to batch, as required by 21 CFR 111.205(a). Specifically, during the current inspection you acknowledged that your firm does not have MMRs for the dietary supplements that you manufacture.

Key Entities Identified

21 CFR 111.70 21 CFR 111.70 21 CFR 111.205 section 403(f) section 403(i) section 403(q) Lead

Frequently Asked Questions

What did the FDA find wrong with Black Seed Herb, Inc.?
The FDA issued a warning letter citing misbranding, cgmp violations related to their products or manufacturing practices.
Are Black Seed Herb, Inc. products safe to use?
Based on the FDA's findings, consumers should exercise caution. The company was found to have misbranding that may affect product safety.
What should I do if I've used Black Seed Herb, Inc. products?
If you have used products from Black Seed Herb, Inc. and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter
Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.